CCL17 and esophageal squamous cell carcinoma: Besides, reduced expressions of MMP2 and MMP9 upon AZD2098 treatment also indicated that the promoting effects of CCL17 on ESCC cell migration and invasion were partially abolished by AZD2098 treatment (Fig. 6C).